标题
New treatments for levodopa-induced motor complications
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 30, Issue 11, Pages 1451-1460
出版商
Wiley
发表日期
2015-08-21
DOI
10.1002/mds.26362
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
- (2015) Tomoyoshi Kondo et al. CLINICAL NEUROPHARMACOLOGY
- Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease
- (2015) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
- (2015) D. Calandrella et al. NEUROLOGY
- Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
- (2014) S. Mazzucchi et al. ACTA NEUROLOGICA SCANDINAVICA
- Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth
- (2014) Alfonso Fasano et al. CLINICAL NEUROPHARMACOLOGY
- Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
- (2014) Manuela Pilleri et al. Expert Opinion On Drug Safety
- Safinamide for the treatment of Parkinson's disease
- (2014) Livia Dézsi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
- (2014) Santiago Perez-Lloret et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease
- (2014) María T. Cáceres-Redondo et al. JOURNAL OF NEUROLOGY
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Can a new trial end controversy over when to use levodopa?
- (2014) Olivier Rascol Nature Reviews Neurology
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery?
- (2013) K. Ray Chaudhuri et al. JOURNAL OF NEURAL TRANSMISSION
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Extended-release carbidopa-levodopa in Parkinson's disease
- (2013) Olivier Rascol LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- Wearing Off, Dyskinesia, and the Use of Continuous Drug Delivery in Parkinson's Disease
- (2013) Peter Jenner NEUROLOGIC CLINICS
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
- (2013) Erwan Bézard et al. NEUROSCIENCE RESEARCH
- Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys
- (2013) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Actively Transported Levodopa Prodrug XP21279
- (2012) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over (“n-of-1”) exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients
- (2012) François Tison et al. PARKINSONISM & RELATED DISORDERS
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
- (2011) Susan H. Fox et al. MOVEMENT DISORDERS
- Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinsonʼs Disease
- (2010) Angelo Antonini et al. CNS DRUGS
- Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
- (2010) László E. Kiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serotonin and Parkinson's disease: On movement, mood, and madness
- (2009) Susan H. Fox et al. MOVEMENT DISORDERS
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search